NAOMI PETERS: Open Payments
NPI 1073284535 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 15 payments from 9 companies in 2025. Trend: 2023 $317 · 2024 $527 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $164 |
| PFIZER INC. | 3 | $52 |
| E.R. Squibb & Sons, L.L.C. | 3 | $46 |
| Abbott Laboratories | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
| Philips North America LLC | 1 | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
Products named: SAPIEN 3 Ultra RESILIA, ELIQUIS, CAMZYOS, LEQVIO, ASSURITY, FUROSCIX, Ambulatory Monitoring & Diagnostics Undivided, LifeVest.
Industry payments across LA — which companies pay providers there.
